-
Analyst Opinions
NewSports Tourism Analysis by Key Trends, Tourist Profile, Sponsorship, Challenges and Opportunities, 2024
Sports Tourism Market Report Overview Sports tourism is a growing segment of the travel industry that involves individuals traveling to different destinations to participate in or watch sports events. It encompasses a wide range of activities and experiences, from attending major international sporting events to participating in local tournaments or simply visiting sports-related attractions. This ‘Sports Tourism Analysis’ report provides valuable insights into the sport tourism industry. It analyzes the key market trends, tourist profiles, and sports sponsorship activities in...
-
Sector Analysis
ICC Mens Cricket World Cup, 2023 – Post Event Analysis
ICC Mens Cricket World Cup, 2023 Report Overview The ICC Mens Cricket World Cup, 2023 had an estimated annual sponsorship revenue of $93,475,000 in 2023. The sporting event witnessed Australia declared the winner and India the runner-up. The tournament attracted a record of 1.25 million spectators. Disney+ Hotstar broke a viewership record of 59 million for the Men’s World Cup Final. The ICC Mens Cricket World Cup, 2023 research report provides a comprehensive analysis of the sponsorship portfolio, deal value,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KIN-3248 in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KIN-3248 in Pancreatic Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KIN-3248 in Pancreatic Cancer Drug Details: KIN-3248 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KIN-3248 in Bile Duct Cancer (Cholangiocarcinoma)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. KIN-3248 in Bile Duct Cancer (Cholangiocarcinoma) Drug Details: KIN-3248 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KIN-3248 in Transitional Cell Carcinoma (Urothelial Cell Carcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KIN-3248 in Transitional Cell Carcinoma (Urothelial Cell Carcinoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.KIN-3248 in Transitional Cell Carcinoma (Urothelial Cell Carcinoma) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SD-101 in Pancreatic Ductal Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SD-101 in Pancreatic Ductal Adenocarcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SD-101 in Pancreatic Ductal Adenocarcinoma Drug Details: SD-101 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SD-101 in Hepatocellular Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SD-101 in Hepatocellular Carcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SD-101 in Hepatocellular Carcinoma Drug Details: SD-101 is under development for the...